TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Efficacy Trial of a Computer Decision Support System Compared to Usual Care for Depression Treatment in Primary Care
Brief Summary: The purpose of this study was designed to test the feasibility and effectiveness of implementing a Computerized Decision Support System for depression (CDSS-D) during acute care in a primary care setting.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: computer-based decision support for asthma management | Intervention Type: DEVICE; Name: computer-based decision support for asthma management; Assigned to Arm(s): 2
B: Arm Label: EMR reminder; Type: EXPERIMENTAL; Interventions: Other: EMR Reminder | Arm Label: EMR reminder + Panel management; Type: EXPERIMENTAL; Interventions: Other: EMR Reminder + Panel management | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: EMR Reminder; Assigned to Arm(s): EMR reminder | Intervention Type: OTHER; Name: EMR Reminder + Panel management; Assigned to Arm(s): EMR reminder + Panel management
C: Arm Label: CDSS-D; Type: EXPERIMENTAL; Interventions: Other: Computerized Decision Support System for Depression (CDSS-D) | Arm Label: UC; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care (UC) | Intervention Type: OTHER; Name: Computerized Decision Support System for Depression (CDSS-D); Assigned to Arm(s): CDSS-D | Intervention Type: OTHER; Name: Usual Care (UC); Assigned to Arm(s): UC
D: Arm Label: Controls ("not tested"); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention ("tested"); Type: ACTIVE_COMPARATOR; Interventions: Genetic: Pharmacogenetic testing | Intervention Type: GENETIC; Name: Pharmacogenetic testing; Assigned to Arm(s): Intervention ("tested")

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blinded, Tolerability and Immunogenicity Study of a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered Concomitantly With GARDASIL to 16- to 26- Year-Old Women
Brief Summary: The purpose of this study is to evaluate vaccine immunogenicity and how well the body tolerates V504 when given with Gardasil.


Options:
A: Arm Label: 9- to 15-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 2); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 3); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Males (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 16- to 26-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Intervention Type: BIOLOGICAL; Name: V503; Assigned to Arm(s): 16- to 26-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 2), 9- to 15-Year-Old Females (Lot 3), 9- to 15-Year-Old Males (Lot 1)
B: Arm Label: Cervarix & Engerix Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: HPV Vaccine (GSK580299) Cervarix TM, Biological: Engerix B | Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: HPV Vaccine (GSK580299) Cervarix TM | Arm Label: Engerix Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Engerix B | Intervention Type: BIOLOGICAL; Name: HPV Vaccine (GSK580299) Cervarix TM; Assigned to Arm(s): Cervarix & Engerix Group, Cervarix Group | Intervention Type: BIOLOGICAL; Name: Engerix B; Assigned to Arm(s): Cervarix & Engerix Group, Engerix Group
C: Intervention Type: BIOLOGICAL; Name: HPV-16/18 L1/AS04; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: V504, Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine, Biological: Comparator: Placebo (unspecified) | Intervention Type: BIOLOGICAL; Name: V504; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine; Assigned to Arm(s): 1, 2 | Intervention Type: BIOLOGICAL; Name: Comparator: Placebo (unspecified); Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Urinary Postpartum Handicap Prevention: Pelvic Floor Exercises vs Control. Multicentric Randomized Trial
Brief Summary: Objective: Compare pelvic floor disorders (urinary incontinence, anal incontinence, genital prolapse, perineal pain, sexual troubles) 12 month after a first delivery between a group of women with prenatal pelvic floor exercises and a control group.

Hypothesis: Prenatal pelvic floor exercises reduce postpartum urinary incontinence.


Options:
A: Arm Label: stabilization exercises; Type: EXPERIMENTAL; Interventions: Other: Stabilization exercise | Arm Label: control group; Type: EXPERIMENTAL; Interventions: Other: Control group | Intervention Type: OTHER; Name: Stabilization exercise; Assigned to Arm(s): stabilization exercises | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): control group
B: Arm Label: Rééducation; Type: EXPERIMENTAL; Interventions: Other: Pelvic floor muscle training with physiotherapist, Other: Written information about kegel exercises | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Written information about kegel exercises | Intervention Type: OTHER; Name: Pelvic floor muscle training with physiotherapist; Assigned to Arm(s): Rééducation | Intervention Type: OTHER; Name: Written information about kegel exercises; Assigned to Arm(s): Control, Rééducation
C: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Educational Workshop | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Educational Workshop; Assigned to Arm(s): Intervention
D: Arm Label: Exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise group | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise group; Assigned to Arm(s): Exercise group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Urinary Postpartum Handicap Prevention: Pelvic Floor Exercises vs Control. Multicentric Randomized Trial
Brief Summary: Objective: Compare pelvic floor disorders (urinary incontinence, anal incontinence, genital prolapse, perineal pain, sexual troubles) 12 month after a first delivery between a group of women with prenatal pelvic floor exercises and a control group.

Hypothesis: Prenatal pelvic floor exercises reduce postpartum urinary incontinence.


Options:
A: Arm Label: Rééducation; Type: EXPERIMENTAL; Interventions: Other: Pelvic floor muscle training with physiotherapist, Other: Written information about kegel exercises | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Written information about kegel exercises | Intervention Type: OTHER; Name: Pelvic floor muscle training with physiotherapist; Assigned to Arm(s): Rééducation | Intervention Type: OTHER; Name: Written information about kegel exercises; Assigned to Arm(s): Control, Rééducation
B: Arm Label: 1 Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: 2 Bladder Health Class; Type: EXPERIMENTAL; Interventions: Behavioral: Bladder Health class | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): 1 Usual Care | Intervention Type: BEHAVIORAL; Name: Bladder Health class; Assigned to Arm(s): 2 Bladder Health Class
C: Arm Label: Acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture | Arm Label: Sham acupuncture; Type: SHAM_COMPARATOR; Interventions: Other: Sham acupuncture | Intervention Type: OTHER; Name: Acupuncture; Assigned to Arm(s): Acupuncture | Intervention Type: OTHER; Name: Sham acupuncture; Assigned to Arm(s): Sham acupuncture
D: Arm Label: G1; Type: EXPERIMENTAL; Interventions: Procedure: Pregnants for receive the physical therapy guide | Intervention Type: PROCEDURE; Name: Pregnants for receive the physical therapy guide; Assigned to Arm(s): G1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Urinary Postpartum Handicap Prevention: Pelvic Floor Exercises vs Control. Multicentric Randomized Trial
Brief Summary: Objective: Compare pelvic floor disorders (urinary incontinence, anal incontinence, genital prolapse, perineal pain, sexual troubles) 12 month after a first delivery between a group of women with prenatal pelvic floor exercises and a control group.

Hypothesis: Prenatal pelvic floor exercises reduce postpartum urinary incontinence.


Options:
A: Arm Label: G1; Type: EXPERIMENTAL; Interventions: Procedure: Pregnants for receive the physical therapy guide | Intervention Type: PROCEDURE; Name: Pregnants for receive the physical therapy guide; Assigned to Arm(s): G1
B: Arm Label: Exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Arm Label: non-exercice; Type: OTHER; Interventions: Behavioral: preparation of the delivery | Intervention Type: BEHAVIORAL; Name: preparation of the delivery; Assigned to Arm(s): Exercice, non-exercice
C: Arm Label: Rééducation; Type: EXPERIMENTAL; Interventions: Other: Pelvic floor muscle training with physiotherapist, Other: Written information about kegel exercises | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Written information about kegel exercises | Intervention Type: OTHER; Name: Pelvic floor muscle training with physiotherapist; Assigned to Arm(s): Rééducation | Intervention Type: OTHER; Name: Written information about kegel exercises; Assigned to Arm(s): Control, Rééducation
D: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.


Options:
A: Arm Label: Counseling for LAM; Type: ACTIVE_COMPARATOR; Interventions: Drug: Counseling for LAM+ LNG-EC | Arm Label: Counseling for LAM+ LNG-EC; Type: EXPERIMENTAL; Interventions: Drug: Counseling for LAM+ LNG-EC | Intervention Type: DRUG; Name: Counseling for LAM+ LNG-EC; Assigned to Arm(s): Counseling for LAM, Counseling for LAM+ LNG-EC
B: Intervention Type: DRUG; Name: CDB-2914; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: levonorgestrel; Assigned to Arm(s): N/A
C: Arm Label: Copper IUD; Type: N/A; Interventions: Drug: Copper IUD | Arm Label: Levonorgestrel IUD; Type: N/A; Interventions: Drug: Levonorgestrel IUD | Intervention Type: DRUG; Name: Copper IUD; Assigned to Arm(s): Copper IUD | Intervention Type: DRUG; Name: Levonorgestrel IUD; Assigned to Arm(s): Levonorgestrel IUD
D: Arm Label: CDB-2914; Type: EXPERIMENTAL; Interventions: Drug: CDB-2914 | Arm Label: Levonorgestrel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Levonorgestrel | Intervention Type: DRUG; Name: CDB-2914; Assigned to Arm(s): CDB-2914 | Intervention Type: DRUG; Name: Levonorgestrel; Assigned to Arm(s): Levonorgestrel

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The purpose of this study is to assess the safety and efficacy of CDB-2914 in comparison to levonorgestrel for preventing pregnancy up to 5 days after unprotected sexual intercourse.


Options:
A: Arm Label: Counseling for LAM; Type: ACTIVE_COMPARATOR; Interventions: Drug: Counseling for LAM+ LNG-EC | Arm Label: Counseling for LAM+ LNG-EC; Type: EXPERIMENTAL; Interventions: Drug: Counseling for LAM+ LNG-EC | Intervention Type: DRUG; Name: Counseling for LAM+ LNG-EC; Assigned to Arm(s): Counseling for LAM, Counseling for LAM+ LNG-EC
B: Arm Label: CDB-2914; Type: EXPERIMENTAL; Interventions: Drug: CDB-2914 | Arm Label: Levonorgestrel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Levonorgestrel | Intervention Type: DRUG; Name: CDB-2914; Assigned to Arm(s): CDB-2914 | Intervention Type: DRUG; Name: Levonorgestrel; Assigned to Arm(s): Levonorgestrel
C: Arm Label: Copper IUD; Type: N/A; Interventions: Drug: Copper IUD | Arm Label: Levonorgestrel IUD; Type: N/A; Interventions: Drug: Levonorgestrel IUD | Intervention Type: DRUG; Name: Copper IUD; Assigned to Arm(s): Copper IUD | Intervention Type: DRUG; Name: Levonorgestrel IUD; Assigned to Arm(s): Levonorgestrel IUD
D: Intervention Type: BEHAVIORAL; Name: Increased access to emergency contraceptive pills; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants
Brief Summary: The purpose of this study is to assess the safety and efficacy of inhaled nitric oxide to reduce the risk of chronic lung disease in pre-term infants with respiratory distress, and to assess the long-term effects of the therapy on the development of these children over 7 years of clinical follow-up.


Options:
A: Arm Label: Inhaled Nitric Oxide (iNO); Type: EXPERIMENTAL; Interventions: Drug: iNO | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: iNO; Assigned to Arm(s): Inhaled Nitric Oxide (iNO) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Inhaled Nitric Oxide (INO); Type: ACTIVE_COMPARATOR; Interventions: Drug: Nitric oxide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nitric oxide; Assigned to Arm(s): Inhaled Nitric Oxide (INO) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Intervention Type: PROCEDURE; Name: mechanical ventilation; Assigned to Arm(s): N/A
D: Arm Label: Inhaled Nitric Oxide (iNO); Type: EXPERIMENTAL; Interventions: Drug: Inhaled Nitric Oxide (iNO) | Arm Label: Nitrogen (placebo); Type: PLACEBO_COMPARATOR; Interventions: Drug: Nitrogen (placebo) | Intervention Type: DRUG; Name: Inhaled Nitric Oxide (iNO); Assigned to Arm(s): Inhaled Nitric Oxide (iNO) | Intervention Type: DRUG; Name: Nitrogen (placebo); Assigned to Arm(s): Nitrogen (placebo)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivation and Patch Treatment for HIV-positive Smokers
Brief Summary: The purpose of this study is to develop and evaluate a brief, clinic-based smoking cessation treatment for an HIV+ population. We compared two treatments, a brief advice and follow-up plus nicotine patch treatment(Standard Care; SC) and brief advice and follow-up, nicotine patch, with the addition of a tailored motivational intervention and behavioral skills counseling for smoking cessation (Motivationally-Enhanced; ME), in a randomized controlled trial. We hypothesized that those HIV+ participants receiving the ME will demonstrate greater biochemically verified smoking abstinence rates at 6-month follow-up than those receiving the SC control treatment. All study participants were offered use of the nicotine patch.


Options:
A: Arm Label: Intensive behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Positively Smoke Free | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Positively Smoke Free; Assigned to Arm(s): Intensive behavioral intervention | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
B: Arm Label: Hospital phone counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Counseling | Arm Label: Fax-to-quit; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fax-to-quit | Intervention Type: BEHAVIORAL; Name: Telephone Counseling; Assigned to Arm(s): Hospital phone counseling | Intervention Type: BEHAVIORAL; Name: Fax-to-quit; Assigned to Arm(s): Fax-to-quit
C: Arm Label: Web-Based Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention | Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention, Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: Web-Based Tailored Smoking Cessation Intervention; Assigned to Arm(s): Standard Care, Web-Based Intervention | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard Care
D: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivation and Patch Treatment for HIV-positive Smokers
Brief Summary: The purpose of this study is to develop and evaluate a brief, clinic-based smoking cessation treatment for an HIV+ population. We compared two treatments, a brief advice and follow-up plus nicotine patch treatment(Standard Care; SC) and brief advice and follow-up, nicotine patch, with the addition of a tailored motivational intervention and behavioral skills counseling for smoking cessation (Motivationally-Enhanced; ME), in a randomized controlled trial. We hypothesized that those HIV+ participants receiving the ME will demonstrate greater biochemically verified smoking abstinence rates at 6-month follow-up than those receiving the SC control treatment. All study participants were offered use of the nicotine patch.


Options:
A: Arm Label: Hospital phone counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Counseling | Arm Label: Fax-to-quit; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Fax-to-quit | Intervention Type: BEHAVIORAL; Name: Telephone Counseling; Assigned to Arm(s): Hospital phone counseling | Intervention Type: BEHAVIORAL; Name: Fax-to-quit; Assigned to Arm(s): Fax-to-quit
B: Arm Label: Integrated Cessation Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Tobacco Treatment | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Tobacco Treatment | Intervention Type: BEHAVIORAL; Name: Tobacco Treatment; Assigned to Arm(s): Integrated Cessation Counseling, Usual Care
C: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement
D: Arm Label: Enhanced PTSD Health Buddy and Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivation Interviewing Counseling | Arm Label: Usual PTSD Health Buddy Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivation Interviewing Counseling; Assigned to Arm(s): Enhanced PTSD Health Buddy and Motivational Interviewing

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Motivation and Patch Treatment for HIV-positive Smokers
Brief Summary: The purpose of this study is to develop and evaluate a brief, clinic-based smoking cessation treatment for an HIV+ population. We compared two treatments, a brief advice and follow-up plus nicotine patch treatment(Standard Care; SC) and brief advice and follow-up, nicotine patch, with the addition of a tailored motivational intervention and behavioral skills counseling for smoking cessation (Motivationally-Enhanced; ME), in a randomized controlled trial. We hypothesized that those HIV+ participants receiving the ME will demonstrate greater biochemically verified smoking abstinence rates at 6-month follow-up than those receiving the SC control treatment. All study participants were offered use of the nicotine patch.


Options:
A: Arm Label: Standard Care; Type: EXPERIMENTAL; Interventions: Behavioral: Standard Care | Arm Label: Motivational Enhancement; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Enhancement | Intervention Type: BEHAVIORAL; Name: Standard Care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Motivational Enhancement; Assigned to Arm(s): Motivational Enhancement
B: Arm Label: Motivation Interviewing/CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing/CBT | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: CONcise Tapes Reviewing Obstacles to healthy Living (CONTROL) | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing/CBT; Assigned to Arm(s): Motivation Interviewing/CBT | Intervention Type: OTHER; Name: CONcise Tapes Reviewing Obstacles to healthy Living (CONTROL); Assigned to Arm(s): Control
C: Arm Label: Brief Advice; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Advice (BA) | Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing (MI) | Arm Label: Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education (HE) | Intervention Type: BEHAVIORAL; Name: Brief Advice (BA); Assigned to Arm(s): Brief Advice | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing (MI); Assigned to Arm(s): Motivational Interviewing | Intervention Type: BEHAVIORAL; Name: Health Education (HE); Assigned to Arm(s): Health Education
D: Arm Label: 1 Nix Individual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Nix Individual | Arm Label: 2 Fimpa dig fri; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Fimpa dig fri | Intervention Type: BEHAVIORAL; Name: Nix Individual; Assigned to Arm(s): 1 Nix Individual | Intervention Type: BEHAVIORAL; Name: Fimpa dig fri; Assigned to Arm(s): 2 Fimpa dig fri

Answer: A